Report Detail
Global Sevoflurane For Inhalation Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4745354 |
- 28 September, 2026 |
- Global |
- 88 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Sevoflurane For Inhalation market size was valued at US$ 1270 million in 2025 and is forecast to a readjusted size of US$ 1615 million by 2032 with a CAGR of 3.5% during review period.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
This report is a detailed and comprehensive analysis for global Sevoflurane For Inhalation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sevoflurane For Inhalation market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sevoflurane For Inhalation market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sevoflurane For Inhalation market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Sevoflurane For Inhalation market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sevoflurane For Inhalation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sevoflurane For Inhalation market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sevoflurane For Inhalation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
250ml/Bottle
120ml/Bottle
Other
Market segment by Application
Hospital
Clinics
Other
Major players covered
Hengrui
Baxter
Maruishi
AbbVie
Piramal
Viatris
PT Novell Pharmaceutical
Lunan Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sevoflurane For Inhalation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sevoflurane For Inhalation, with price, sales quantity, revenue, and global market share of Sevoflurane For Inhalation from 2021 to 2026.
Chapter 3, the Sevoflurane For Inhalation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sevoflurane For Inhalation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sevoflurane For Inhalation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sevoflurane For Inhalation.
Chapter 14 and 15, to describe Sevoflurane For Inhalation sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Sevoflurane For Inhalation Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 250ml/Bottle
- 1.3.3 120ml/Bottle
- 1.3.4 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Sevoflurane For Inhalation Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinics
- 1.4.4 Other
- 1.5 Global Sevoflurane For Inhalation Market Size & Forecast
- 1.5.1 Global Sevoflurane For Inhalation Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Sevoflurane For Inhalation Sales Quantity (2021-2032)
- 1.5.3 Global Sevoflurane For Inhalation Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Hengrui
- 2.1.1 Hengrui Details
- 2.1.2 Hengrui Major Business
- 2.1.3 Hengrui Sevoflurane For Inhalation Product and Services
- 2.1.4 Hengrui Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Hengrui Recent Developments/Updates
- 2.2 Baxter
- 2.2.1 Baxter Details
- 2.2.2 Baxter Major Business
- 2.2.3 Baxter Sevoflurane For Inhalation Product and Services
- 2.2.4 Baxter Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Baxter Recent Developments/Updates
- 2.3 Maruishi
- 2.3.1 Maruishi Details
- 2.3.2 Maruishi Major Business
- 2.3.3 Maruishi Sevoflurane For Inhalation Product and Services
- 2.3.4 Maruishi Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Maruishi Recent Developments/Updates
- 2.4 AbbVie
- 2.4.1 AbbVie Details
- 2.4.2 AbbVie Major Business
- 2.4.3 AbbVie Sevoflurane For Inhalation Product and Services
- 2.4.4 AbbVie Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 AbbVie Recent Developments/Updates
- 2.5 Piramal
- 2.5.1 Piramal Details
- 2.5.2 Piramal Major Business
- 2.5.3 Piramal Sevoflurane For Inhalation Product and Services
- 2.5.4 Piramal Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Piramal Recent Developments/Updates
- 2.6 Viatris
- 2.6.1 Viatris Details
- 2.6.2 Viatris Major Business
- 2.6.3 Viatris Sevoflurane For Inhalation Product and Services
- 2.6.4 Viatris Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Viatris Recent Developments/Updates
- 2.7 PT Novell Pharmaceutical
- 2.7.1 PT Novell Pharmaceutical Details
- 2.7.2 PT Novell Pharmaceutical Major Business
- 2.7.3 PT Novell Pharmaceutical Sevoflurane For Inhalation Product and Services
- 2.7.4 PT Novell Pharmaceutical Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 PT Novell Pharmaceutical Recent Developments/Updates
- 2.8 Lunan Pharma
- 2.8.1 Lunan Pharma Details
- 2.8.2 Lunan Pharma Major Business
- 2.8.3 Lunan Pharma Sevoflurane For Inhalation Product and Services
- 2.8.4 Lunan Pharma Sevoflurane For Inhalation Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Lunan Pharma Recent Developments/Updates
3 Competitive Environment: Sevoflurane For Inhalation by Manufacturer
- 3.1 Global Sevoflurane For Inhalation Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Sevoflurane For Inhalation Revenue by Manufacturer (2021-2026)
- 3.3 Global Sevoflurane For Inhalation Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Sevoflurane For Inhalation by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Sevoflurane For Inhalation Manufacturer Market Share in 2025
- 3.4.3 Top 6 Sevoflurane For Inhalation Manufacturer Market Share in 2025
- 3.5 Sevoflurane For Inhalation Market: Overall Company Footprint Analysis
- 3.5.1 Sevoflurane For Inhalation Market: Region Footprint
- 3.5.2 Sevoflurane For Inhalation Market: Company Product Type Footprint
- 3.5.3 Sevoflurane For Inhalation Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Sevoflurane For Inhalation Market Size by Region
- 4.1.1 Global Sevoflurane For Inhalation Sales Quantity by Region (2021-2032)
- 4.1.2 Global Sevoflurane For Inhalation Consumption Value by Region (2021-2032)
- 4.1.3 Global Sevoflurane For Inhalation Average Price by Region (2021-2032)
- 4.2 North America Sevoflurane For Inhalation Consumption Value (2021-2032)
- 4.3 Europe Sevoflurane For Inhalation Consumption Value (2021-2032)
- 4.4 Asia-Pacific Sevoflurane For Inhalation Consumption Value (2021-2032)
- 4.5 South America Sevoflurane For Inhalation Consumption Value (2021-2032)
- 4.6 Middle East & Africa Sevoflurane For Inhalation Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Sevoflurane For Inhalation Sales Quantity by Type (2021-2032)
- 5.2 Global Sevoflurane For Inhalation Consumption Value by Type (2021-2032)
- 5.3 Global Sevoflurane For Inhalation Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Sevoflurane For Inhalation Sales Quantity by Application (2021-2032)
- 6.2 Global Sevoflurane For Inhalation Consumption Value by Application (2021-2032)
- 6.3 Global Sevoflurane For Inhalation Average Price by Application (2021-2032)
7 North America
- 7.1 North America Sevoflurane For Inhalation Sales Quantity by Type (2021-2032)
- 7.2 North America Sevoflurane For Inhalation Sales Quantity by Application (2021-2032)
- 7.3 North America Sevoflurane For Inhalation Market Size by Country
- 7.3.1 North America Sevoflurane For Inhalation Sales Quantity by Country (2021-2032)
- 7.3.2 North America Sevoflurane For Inhalation Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Sevoflurane For Inhalation Sales Quantity by Type (2021-2032)
- 8.2 Europe Sevoflurane For Inhalation Sales Quantity by Application (2021-2032)
- 8.3 Europe Sevoflurane For Inhalation Market Size by Country
- 8.3.1 Europe Sevoflurane For Inhalation Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Sevoflurane For Inhalation Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Sevoflurane For Inhalation Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Sevoflurane For Inhalation Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Sevoflurane For Inhalation Market Size by Region
- 9.3.1 Asia-Pacific Sevoflurane For Inhalation Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Sevoflurane For Inhalation Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Sevoflurane For Inhalation Sales Quantity by Type (2021-2032)
- 10.2 South America Sevoflurane For Inhalation Sales Quantity by Application (2021-2032)
- 10.3 South America Sevoflurane For Inhalation Market Size by Country
- 10.3.1 South America Sevoflurane For Inhalation Sales Quantity by Country (2021-2032)
- 10.3.2 South America Sevoflurane For Inhalation Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Sevoflurane For Inhalation Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Sevoflurane For Inhalation Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Sevoflurane For Inhalation Market Size by Country
- 11.3.1 Middle East & Africa Sevoflurane For Inhalation Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Sevoflurane For Inhalation Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Sevoflurane For Inhalation Market Drivers
- 12.2 Sevoflurane For Inhalation Market Restraints
- 12.3 Sevoflurane For Inhalation Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Sevoflurane For Inhalation and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Sevoflurane For Inhalation
- 13.3 Sevoflurane For Inhalation Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Sevoflurane For Inhalation Typical Distributors
- 14.3 Sevoflurane For Inhalation Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Sevoflurane For Inhalation. Industry analysis & Market Report on Sevoflurane For Inhalation is a syndicated market report, published as Global Sevoflurane For Inhalation Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Sevoflurane For Inhalation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
